Van professionele vertalers, bedrijven, webpagina's en gratis beschikbare vertaalbronnen.
note for guidance on clinical investigation of medical products in the treatment of obsessive-compulsive disorder
2) – addendum on paediatric oncology.
adults: • major depressive episodes • obsessive-compulsive disorder • bulimia nervosa:
Ιδεοληπτική- Ψυχαναγκαστική ∆ιαταραχή
the body of symptoms includes phobic anxiety, avoidance behaviour, obsessive-compulsive disorder and personality change.
Η συμπτωματολογία περιλαμβάνει αγχώδεις διαταραχές φοβικού τύπου, συμπεριφορές αποφυγής, σύνδρομο επανάληψης και διαταραχές χαρακτήρα.
increased hostility occurred particularly in children with obsessive compulsive disorder, and especially in younger children less than 12 years of age.
Θεραπεία ∆εν υπάρχει κάποιο συγκεκριµένο αντίδοτο.
concept paper on the development of a cpmp note for guidance on clinical investigation of medicinal products for the treatment of obsessive compulsive disorder.
concept paper on the development of a cpmp note for guidance on clinical investigation of medicinal products for the treatment of obsessive compulsive disorder.
insufficient evidence has been made available concerning the efficacy of paroxetine for the treatment of obsessive compulsive disorder and social anxiety/ social phobia.
Η συνιστώµενη ηµερήσια δόση της παροξετίνης είναι 40mg/ ηµερησίως για ΙΨ∆ και διαταραχή πανικού και 20mg/ ηµερησίως για τις άλλες ενδείξεις.
prozac is authorised in most eu member states for the treatment of major depressive episodes, obsessive-compulsive disorder and bulimia nervosa in adults.
1084/ 2003 της Επιτροπής.